Sarepta Therapeutics Inc (SRPT)
117.18
-0.65
(-0.55%)
USD |
NASDAQ |
Apr 18, 12:59
Sarepta Therapeutics Cash from Operations (TTM): -500.99M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -500.99M |
| September 30, 2023 | -538.73M |
| June 30, 2023 | -488.99M |
| March 31, 2023 | -433.57M |
| December 31, 2022 | -325.35M |
| September 30, 2022 | -262.28M |
| June 30, 2022 | -321.64M |
| March 31, 2022 | -363.98M |
| December 31, 2021 | -443.17M |
| September 30, 2021 | -588.38M |
| June 30, 2021 | -702.24M |
| March 31, 2021 | -700.70M |
| December 31, 2020 | 107.47M |
| September 30, 2020 | 118.21M |
| June 30, 2020 | 288.96M |
| March 31, 2020 | 317.56M |
| December 31, 2019 | -456.46M |
| September 30, 2019 | -415.09M |
| June 30, 2019 | -460.98M |
| March 31, 2019 | -499.22M |
| December 31, 2018 | -388.66M |
| September 30, 2018 | -297.30M |
| June 30, 2018 | -241.88M |
| March 31, 2018 | -209.78M |
| December 31, 2017 | -232.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -282.17M |
| June 30, 2017 | -284.88M |
| March 31, 2017 | -243.02M |
| December 31, 2016 | -245.82M |
| September 30, 2016 | -195.86M |
| June 30, 2016 | -181.56M |
| March 31, 2016 | -166.80M |
| December 31, 2015 | -149.46M |
| September 30, 2015 | -143.64M |
| June 30, 2015 | -132.65M |
| March 31, 2015 | -143.62M |
| December 31, 2014 | -128.54M |
| September 30, 2014 | -120.91M |
| June 30, 2014 | -105.47M |
| March 31, 2014 | -77.97M |
| December 31, 2013 | -64.70M |
| September 30, 2013 | -54.03M |
| June 30, 2013 | -41.96M |
| March 31, 2013 | -35.64M |
| December 31, 2012 | -29.69M |
| September 30, 2012 | -28.18M |
| June 30, 2012 | -27.90M |
| March 31, 2012 | -22.66M |
| December 31, 2011 | -23.68M |
| September 30, 2011 | -19.92M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-702.24M
Minimum
Jun 2021
317.56M
Maximum
Mar 2020
-324.75M
Average
-433.57M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
| CytomX Therapeutics Inc | -56.04M |
| PTC Therapeutics Inc | -158.42M |
| Vertex Pharmaceuticals Inc | 3.537B |
| Puma Biotechnology Inc | 27.01M |
| Regenxbio Inc | -218.41M |